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Impact Statements 
Snail1 expression in tumour stroma is associated with a lower specific survival in colon 
cancer patients. The present study, using established human primary normal and cancer 
associated fibroblasts, normal and tumour colon cancer samples, ectopic Snail1 
modified fibroblasts and colon cell and xenografted nude mice models, reveals, for the 
first time, that Snail1 is necessary for the pro-tumorogenic effects of fibroblasts by 
controlling migration and proliferation on colon cancer cells. 
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ABSTRACT 
Snail1 is a transcriptional factor that plays an important role in epithelial-mesenchymal 
transition and in the acquisition of invasive properties by epithelial cells. In colon 
tumours, Snail1 expression in the stroma correlates with lower specific survival of 
cancer patients. However, the role(s) of Snail1 expression in stroma and its association 
with patients’ survival have not been determined. We used human primary Carcinoma 
Associated Fibroblasts (CAFs) or Normal Fibroblasts (NFs) and fibroblast cell lines to 
analyze the effects of Snail1 expression on the pro-tumorigenic capabilities in colon 
cancer cells. Snail1 expression was higher in CAFs than in NFs and, as well as α-SMA, 
a classic marker of activated CAFs. Moreover, in tumour samples from 50 colon cancer 
patients, SNAI1 expression was associated with expression of other CAF markers, such 
as α-SMA and FAP. Interestingly, co-culture of CAFs with colon cells induced a 
significant increase in epithelial cell migration and proliferation, which was associated 
with endogenous SNAI1 expression levels. Ectopic manipulation of Snail1 in fibroblasts 
demonstrated that Snail1 expression controlled migration as well as proliferation of co-
cultured colon cancer cells in a paracrine manner. Furthermore, expression of Snail1 in 
fibroblasts was required for the co-adjuvant effect of these cells on colon cancer cell 
growth and invasion when co-xenografted in nude mice. Finally, cytokine profile 
changes, particularly MCP3 expression, in fibroblasts are put forward as mediators of 
Snail1-derived effects on colon tumour cell migration. In summary, these studies 
demonstrate that Snail1 is necessary for the pro-tumorogenic effects of fibroblasts on 
colon cancer cells. 
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INTRODUCTION 
Snail1 transcriptional factor is a key factor for triggering Epithelial-Mesenchymal 
Transition (EMT), a process characterized by the loss of epithelial characteristics and 
the acquisition of mesenchymal traits and higher motility.
1
 
Snail1 expression is observed at different stages during embryo development and is 
required for numerous developmental processes.
2
 Snail1 expression and EMT features 
have also been observed in breast, prostate, lung, ovarian, melanoma, colon and 
oesophageal cancers.
3-13
 In most cases, Snail1 is detected in the invasive areas of the 
tumour. An analysis of colon tumours has shown that Snail1 is mainly detected in the 
tumour stroma, in cells with a fibroblast phenotype. Furthermore, Snail1 expression in 
tumour stroma is associated with shorter specific survival in colon cancer patients.
12
 In 
addition, we recently noted the paracrine effects of Snail1 expression in human colon 
cells, showing down-regulation of CDH1 and VDR gene expression when co-cultured 
with Snail1 over-expressing colon cancer cells.
14
 However, the molecular mechanism 
underlying this association is not yet clear.  
Taking all these data together, this study aimed to characterize Snail1 as a novel 
enhancer of paracrine-derived effects on colon cancer cell migration and proliferation 
and to describe the novel cytokine profile induced by Snail1 expression in fibroblasts. 
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MATERIAL AND METHODS 
Establishment of primary colon NFs and colon cancer CAFs  
For CAF and NF establishment, fresh tumour and normal colon mucosa samples were 
obtained from Puerta de Hierro University Hospital, Majadahonda, and Virgen de la 
Salud Hospital, Toledo, between January and December 2011. Informed written consent 
was obtained from all participants after an explanation of the nature of the study, as 
approved by the Research Ethics Board of Puerta de Hierro Majadahonda University 
Hospital. For CAF establishment and growth details, see Supplementary Information.  
To evaluate the CAF enrichment of the culture, Vimentin and Pan Cytokeratin (PanCK) 
were analysed for immunofluorescence (Supplementary Figure 1A). 
Normal and colon tumour human samples 
The study is based on two consecutive series of 50 and 65 patients who had surgery for 
colon cancer between January 1998 and January 2003. The first patient cohort was a 
subgroup of a cohort previously described by Peña et al., 2005;
15
 and the second, a 
subgroup of a cohort previously described by Herrera et al., 2013.
16
 Informed written 
consent was obtained from all participants, as approved by the Research Ethics Board of 
Puerta de Hierro Majadahonda University Hospital. Colon cancer-derived samples were 
obtained immediately after surgery, snap-frozen in liquid nitrogen and stored at -80ºC 
until processing.   
RNA treatment and Quantitative Real-Time PCR (RT-PCR) 
RNA extraction, target gene mRNA quantification and synthesis of cDNA were 
performed as described elsewhere.
14
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Immunohistochemistry and immunofluorescence analysis in human and mouse 
samples 
The following antibodies were used in this study: SNAI1 mAb EC3 antibody,
17
 anti-
alpha smooth muscle actin antibody [1A4] (Abcam), polyclonal antibody to fibroblast 
activation protein (FAP) alpha (Imgenex, San Diego, CA, USA), monoclonal antibodies 
anti-pan cytokeratin (ab6401, Abcam) and anti-vimentin (ab92547, Abcam); anti Ki67 
(ab21700, Abcam) and anti E-cadherin (Transduction Labs 610182). Procedures were 
performed as described and Supplementary Information.
12, 18
 
Co-culture of tumour colon cells and human colon primary CAFs or fibroblasts 
cell lines for migration assays 
Colon tumour cell lines were co-cultured with colon primary CAFs or fibroblasts cell 
line for migration assays. Cells were co-cultured with physical separation, in a setting in 
which primary CAFs were seeded in the lower compartment of a transwell system and 
colon cells in the upper one. After 48 h, epithelial cells that had reached the lower 
surface of the filter were measured by fluorescence. For procedure and growth details, 
see Supplementary Information. 
Co-culture of tumour colon cells and fibroblast cell lines for proliferation assays 
Proliferation assays were carried out in 24-well plates by co-culturing Snail1-expressing 
cells in the upper chamber of a 0.4 µm trans-well culture (Becton Dickinson) and 
SW480-ADH-GFP cells in the lower one. Cells were grown in DMEM containing 5% 
FBS for 6 days; proliferation rate was analyzed at 3 and 6 days by a fluorescence reader 
(Tecan Infinite 200 Pro).  
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FACS analysis of the cell cycle of colon cancer cells 
Tumour colon cells were incubated with conditioned medium from fibroblasts or CAFs 
for 24h. Afterwards, cells were fixed in 70% ethanol and treated with 0.2 mg/ml RNase 
(Qiagen) and propidium iodide (Sigma Chemical Co.) at 20 μg/ml in PBS. Cell DNA 
content was evaluated in a MACSQuant Analyzer (Miltenyi Biotech). See details in 
Supplementary Information.  
In-vivo xenograft tumour model  
One million HT-29 M6 cells plus 10
5
 MEFs were subcutaneously injected into the flank 
of 8-week-old athymic female nude mice. Growth of the tumour was followed every 
other day after the first week. The study was approved by the Animal Research Ethical 
Committee of the PRBB. N=6. 
Human Protein Cytokine Array 
Conditioned medium was harvested from fibroblasts and incubated with membranes 
containing an array of 80 human cytokine antibodies (RayBio® Human Cytokine 
Antibody Array 5, RayBiotech Inc.). The bound complex was detected with Odyssey 
Infrared Imaging System (Li-Cor) at 800 nm, using Streptavidin DyLight 800 
Conjugates (Rockland Immunochemicals). Details are described in Supplementary 
Information.  
Colon cell migration with recombinant protein 
Colon tumour cell migration assays, developed with medium supplemented with the 
corresponding cytokines, were conducted as described above and in Supplementary 
Information.   
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RESULTS AND DISCUSSION 
Snail1 gene (SNAI1) expression was determined in Cancer-Associated Fibroblasts 
(CAFs), isolated from 13 colon cancer patients, and compared with the expression in 
fibroblasts isolated from normal colon mucosa of 5 colon cancer patients (NFs). SNAI1 
mRNA expression was detected in CAFs from all patients’ samples, with relative 
expression levels between 2.81 and 0.34. Interestingly, expression levels of mRNA 
SNAI1 were higher in CAFs than in fibroblasts from normal colon mucosa (Figure 1A). 
Thus, these data revealing a significant increase of SNAI1 expression in CAFs vs NFs 
suggest that Snail1 can be considered a CAF marker. As a control, α-SMA, a well-
studied marker of these fibroblasts,
19
 was also up-regulated in CAF vs NF 
(Supplementary Figure 1B).   
In view of these data, the association between SNAI1 expression and CAF markers was 
studied in normal and tumour samples of 50 colon cancer patients. As shown in Figure 
1B and 1C, SNAI1 expression was associated with a-SMA and FAP expression markers. 
Moreover, IHC analysis of SNAI1, a-SMA and FAP in human colon tumour samples 
showed staining that overlapped the three markers (Supplementary Figure 1C). 
To investigate the relevance of Snail1 expression in the properties of CAFs, we 
performed migration assays in Boyden chambers using colon cancer cells co-cultured 
with primary CAFs isolated from 11 colon cancer patients. As expected, CAFs 
enhanced LIM1215 cell migration between 8- and 140-fold more than cells cultured 
without fibroblast stimulation. Interestingly, statistical analysis showed direct 
correlation between mRNA SNAI1 expression levels in primary human CAFs and its 
ability to induce colon cancer cell migration (Figure 1D). This correlation was also 
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validated when another colon cancer cell line, SW480-ADH, was used (Supplementary 
Figure 1D). 
These results suggest that the up-regulation of SNAI1 in tumour stroma enhances colon 
cancer cell migration. Therefore, to verify this conclusion we used different fibroblast 
cells in which we ectopically manipulated Snail1 levels (Supplementary Figure 2A). 
Snail1 over-expression in 1.BR3.G human immortalized fibroblasts up-regulated the 
capacity of these cells to increase the migration of SW480-ADH and LIM1215 cells 
over mock-transfected 1.BR3.G cells (Figure 1E and Supplementary Fig 2B, 
respectively).  
The effect of Snail1 depletion in fibroblasts was also analyzed. We took advantage of 
the availability of murine embryo fibroblasts (MEFs) derived from a mouse bearing a 
Snail1-floxed form of this gene (Supplementary Figure 2A).
20
 After depletion of these 
genes by expression of Cre recombinase, the effect of wild-type and Snail1 KO MEFs 
on SW-480 ADH migration was determined. As shown in Figure 1F, SW480-ADH-
Mock cell migration was significantly less when co-cultured with Snail1 KO MEFs than 
when co-cultured with wt MEFs. The different effect on colon cancer cell migration of 
wt and Snail KO MEFs was also confirmed when using HT29-M6 or LIM1215 cells 
(Supplementary Figure 2C and 2D).  
The increase in migration of target cells when co-cultured with cells in which Snail1 
was ectopically expressed was not restricted to fibroblasts: Snail1 expression either in 
SW480-ADH-Snai1 or in HT-29-Snai1 colon cancer cells induced a significant increase 
in the migration of co-cultured SW480-ADH Mock cells (Supplementary Figure 2E and 
2F). 
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These experiments demonstrate that Snail1 expression induces paracrine pro-migratory 
effects on colon cancer cells. We also analyzed whether the proliferation rates of 
epithelial cells increased when co-cultured with Snail1-expressing cells. For this, colon 
cells were co-cultured in 0.4µm Boyden chambers with Snail1-expression or mock 
fibroblasts. Proliferation rate was measured at 3 and 6 days of the co-culture by 
fluorescence. An increase in the SW480-ADH cell proliferation rate was observed when 
co-cultured with 1.BR3.G-Snail1 human fibroblasts (Figure 1G). SW480-ADH cell 
proliferation also increased when Snail1 was expressed in the same cells 
(Supplementary Figure 2G).  
In line with these results, Snail1-expressing fibroblasts statistically increased the 
number of SW480-ADH Mock cells in the S/M phase (Supplementary Figure 2H). In 
parallel, CAFs from nine colon cancer patients, with large differences in their mRNA 
SNAI1 expression levels, offered similar results. There was direct correlation between 
SNAI1 levels of CAFs and the percentage of SW480-ADH cells in the S/M phase 
(Figure 1H).  
The in-vivo significance of these findings was also explored in a xenograft mouse 
model. HT29M6 cells were subcutaneously co-injected with wild-type or Snail KO 
MEFs in 6 mice. As expected, Snail1 immunostaining showed lower Snail1 expression 
in the stromal compartment of tumours derived from co-injection of HT29-M6 and 
Snail1 KO MEFs than in that of tumours in the control group (Supplementary Figure 
3A). As shown in Figure 2A, tumours derived from co-injection of colon cells and Snail 
KO MEFs were significantly smaller than the tumours of the control group. Supporting 
these data, Ki67 immunostaining showed a significant proliferation index decrease in 
tumours from colon cells and Snail1 KO MEFs (Figure 2B). Interestingly, muscular 
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layer invasion was observed in 67% of tumours derived from co-injection of HT29-M6 
and Snail1 wt MEFs, while no tumour from Snail1 KO MEFs showed muscular 
invasion (Figure 2C). In line with these data, down-regulation of E-cadherin was 
observed in tumours derived from colon cancer cells and Snail1 wt MEFs by 
immunohistochemistry (Supplementary Figure 3B). These results demonstrated that 
depletion of Snail from fibroblasts decreased their ability to support xenograft tumour 
growth and invasion and supported in-vitro Snail-derived effects. 
To identify mediators involved in Snail1-dependent paracrine signalling between 
fibroblasts and colon cancer cells, we investigated whether Snail1 expression in 
fibroblasts modifies the production and release of cytokines, growth factors and other 
immuno-modulators. Thus, a human cytokine array with conditioned medium from 
1.BR3.G-Snail1 transfected cells and 1.BR3.G-PCDNA3 as control was performed to 
analyze the protein concentration of 80 human secreted proteins. Four up-regulated 
(GRO-alpha, MCP-3, Fractalkine and I-309) and two down-regulated (IL-10 and G-
CSF) cytokines were observed, indicating a cytokine change profile derived from Snail1 
expression in fibroblasts (Figure 3A).  
These data suggest that the Snail-dependent paracrine effect on colon cancer cells may 
involve cytokine profile changes. Therefore, to verify the effect of these cytokines, 
SW480-ADH-Mock cells were incubated with corresponding recombinant proteins. 
Preliminary results showed an increase in SW480-ADH-Mock cell migration when cells 
were incubated with Fractalkine or MCP3 recombinant proteins (Figure 3B). Similarly, 
a trend toward statistical increase of SW480-ADH-Mock cell migration was observed 
when incubation was with I-309 or GRO-alpha (Figure 3B).  
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Different approaches have attempted to validate further the association between Snail1 
and cytokine expression. Thus, mRNA expression levels of Snail1 and target cytokines 
were analysed in 1) 8 CAFs with different SNAI1 expression levels; 2) Snail1 KO and 
wt MEFs; 3) 1.BR3.G-Snail1 transfected cells and 1.BR3.G-PCDNA3; 4) human colon 
tumour tissues from 65 patients. Interestingly, MCP3 and Snail1 expression levels are 
associated in all experimental approaches (Figure 3C-3F). Remaining cytokines, such as 
GRO-alpha and Fractalkine, also showed statistical association with Snail1 expression 
levels, but not under all conditions (data not shown). Taken together, these data support 
the view that, at least, changes in mRNA and protein expression levels of MCP3 are 
involved in the Snail1-dependent paracrine effect on colon cancer cells.   
In summary, the clinical implication of this study lies in the observation that SNAI1 
expression is up-regulated in the stroma of human colon cancer patients. Moreover, in 
human colon tumour samples, SNAI1 expression was associated with CAF markers, like 
a-SMA and FAP, which have previously been related to colorectal cancer patient 
survival.
18
 In addition, the overlapping immunostaining of SNAI1 and CAF markers in 
parallel sections of tumour samples support these data, which point to the expression of 
SNAI1 as a CAF marker. The identification of new markers for progression in colon and 
other cancers is essential for understanding the cross-talk between fibroblasts and 
cancer cells, which would identify new targets for developing novel strategies to 
interfere with cancer progression. 
Our data describe a novel role of Snail1-derived paracrine effects on cancer cells. Thus, 
Snail expression in fibroblasts increases the tumorogenic abilities of co-cultures of 
colon cancer cells by increasing cell migration and proliferation. Corroborative data 
were also obtained when Snail1 wild-type or knock-out MEFs were used. In addition, 
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data obtained from primary CAFs with similar results to results with cell lines indicate 
the relevance of SNAI1 expression in clinical settings. The in-vivo value of these 
findings is emphasized by the finding that co-injection of tumour cells with Snail KO 
fibroblasts developed smaller tumours with a lower proliferation index and less 
muscular invasion than co-injection with wild-type fibroblasts did. In contrast to our 
results, Snail1 expression has been related to a retard in cell proliferation.
21
 However, 
these studies were performed over-expressing Snail1 in epithelial cells, while our results 
analyse the relevance of Snail1 in fibroblasts and its effect on co-cultured colon cells, 
demonstrating a novel paracrine effects of Snail1-expressing fibroblasts.  
Analysis should be extended to identify the fibroblast-derived mediators of Snail1-
dependent stimulatory in-vitro effects. However, our results suggest that the paracrine 
effect of fibroblasts’ Snail expression engages with cytokine profile changes. Indeed, 
the direct effect of some of these cytokines was assessed in the induction of colon 
tumour cell migration. Moreover, association between MCP3 and Snail1 mRNA 
expression levels was confirmed under different experimental conditions, which suggest 
that this cytokine might be a mediator of Snail1-dependent paracrine effects of 
fibroblasts on cancer cell migration and proliferation. 
In brief, the conclusions of the present study demonstrate the importance of Snail1 
expression in fibroblasts and CAFs, enhancing the pro-tumorogenic abilities of colon 
cancer cells, in a way that involves cytokine profile changes.    
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FIGURE LEGENDS 
Figure 1. SNAI1 expression in human primary CAFs is suggested as an activated 
fibroblast marker and enhances colon cancer migration and proliferation in a 
paracrine manner. Increased expression levels of SNAI1 (A) in CAFs versus NFs. 
Association between SNAI1 expression and α-SMA (B) or FAP (C) gene expression 
levels in human tumour samples. Correlation between SNAI1 expression levels of CAFs 
and migration of co-cultured LIM1215 colon cancer cells (D). Ectopic expression of 
Snail1 in fibroblasts enhanced 48h migration of SW480-ADH-Mock colon cancer cells 
(E). SW480-ADH-Mock migration decreased when co-cultured with knock-out MEFs 
(F). Proliferation of SW480-ADH-Mock cells is stimulated by Snail-expressing 
fibroblasts (G). Correlation of SNAI1 expression levels in CAFs from 9 different 
patients and the percentage of colon cells in phases S+G2-M after incubation with CAF-
conditioned medium (H). 
Figure 2. Snail1-expressing fibroblasts are required for the co-adjuvant effect of 
these cells on colon cancer cell growth and invasion in co-xenografted nude mice. 
Primary tumour growth was monitored for 32 days, showing a reduction of size in 
tumours derived from co-injection of tumour cells and Snail1 KO MEFs (A). There 
were a significant proliferation index, measured by Ki67 immunostaining, and a 
decrease in tumours derived from colon cells and Snail1 KO MEFs (B). Muscular layer 
invasion was observed only in tumours derived from co-injection of colon cells and wt 
MEFs (C). 
Figure 3. Association between MCP3 and Snail1 expression levels in CAFs and 
human tumour tissues. De-regulated proteins in conditioned medium from 1.BR3G-
Snail1 fibroblasts for Mock cells measured by Human Cytokine Array. (A) There was a 
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statistically significant increase in SW480-ADH-Mock tumour colon cell migration 
when cells were incubated with Fractalkine or MCP3 cytokines. Although there was no 
statistical difference, there was an increase of SW480-ADH-Mock cell migration when 
cells were incubated with I-309 and GRO-α cytokines (B). Association between MCP3 
and SNAI1 mRNA expression levels in human primary CAFs (C), in Snail1 KO and wt 
MEFs treated with TGF-β at different times (D), in 1.BR3.G-Snail1 transfected cells 
and 1.BR3.G-PCDNA3 (E) and in human colon tumour tissues from 65 patients (F). 
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SUPPLEMENTARY INFORMATION 
Supplementary methodology 
Establishment of primary colon cancer CAFs 
All the fibroblast strains were derived in the same way from explant cultures. Tissue 
samples from colon tumour were cut into small pieces approximately 2-3 mm
3
 in size 
and seeded in foetal calf serum medium (FCS) with 200u/ml Penicillin, 200ug/ml 
Streptomycin, 100ug/ml Gentamicin and 2.5g/ml Amphotericin B. When outgrowths of 
fibroblasts appeared, the culture medium was replaced by FMB (Lonza) supplemented 
with FGM-2 Bulletkit (Lonza) to facilitate fibroblast growth. The remnants of the tissue 
were carefully washed away and CAFs were routinely maintained in FBM medium at 
37ºC in a humid atmosphere containing 5% CO2. 
Pan-cytokeratin and Vimentin immunofluorescence  
To determine CAF culture enrichment, Vimentin and Pan-cytokeratin were labelled by 
immunofluorescence.  
Briefly, fibroblast cells cultured on pp4 plates were washed with cold phosphate-
buffered saline (PBS) twice and then fixed with cold methanol for 30 sec. Following 5 
washes with PBS (the last one with 0.05% Tween) at room temperature, fixed cells 
were incubated with specific primary antibody to Pan-cytokeratin antibody and 
Vimentin (monoclonal anti-pan cytokeratin, ab6401 Abcam; and monoclonal anti-
vimentin, ab92547 Abcam, respectively) overnight at 4°C. Then, the samples were 
incubated for 1h with appropriate secondary species-labelled IgG Alexa-Flour 488 or 
546 (Invitrogen). After 4 PBS washes, slides were mounted with Vectashield Hard-Set 
mounting media with DAPI (4′,6-diamidino-2-phenylindole, HCl) to view the nuclei 
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(Vector Laboratories Inc.) and were examined with a Nikon Eclipse Ti-S 
Epifluorescence microscope equipped with a DS-L2 digital camera (Nikon). 
Representative samples were taken from diverse areas of each cell culture to assess the 
percentage of positive cells.  
Culture cell lines 
Human colon cancer cell lines and MEFs were cultured in Dulbecco’s modified Eagle 
medium (DMEM, Lonza), supplemented with 10% Fetal Bovine Serum (FBS), 2 mM 
L-glutamine, penicillin (100 units/ml) and streptomycin (100 ng/ml) at 37ºC in a 5% 
CO2 humidified atmosphere. 1.BR3.G immortalized human dermal fibroblasts were 
grown in EMEM (Lonza) with 20% FBS. 
Generation of Snai1 modified cell lines 
SW480-ADH and HT-29 human colon cancer cell lines stably expressing mouse Snai1 
cDNA (SW480-ADH-Snai1 and HT-29-Snai1) or an empty vector (SW480-ADH Mock 
and HT-29 Mock) were generated by retrovirus-mediated gene transfer, as described 
earlier (Palmer et al. 2004). 1.BR3.G human dermal fibroblasts stably expressing mouse 
Snai1 cDNA were obtained by transfection, at 90% confluence, of 24 µg of either 
pcDNA3 SNAI1-HA or control pcDNA3 vector, using Lipofectamine reagent 
(Invitrogen), as recommended by the manufacturer. Then, medium was replaced with 
selective medium containing 1 mg/ml G418 (Sigma) for 3-4 weeks. Snai1 knock-out 
MEFs were generated as described in Batlle et al. (in press).  
Western blot analysis 
90 µg of cell protein lysate were used to analyse Snail1 protein expression by Western 
blotting with a mouse monoclonal antibody (Franci et al. 2006). β-actin was detected 
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with a rabbit polyclonal antibody (ab8227-50; Abcam). Cell protein was extracted with 
RIPA buffer (Sigma) and Halt Protease and Phosphatase Single-Use Inhibitor Cocktail 
(Thermo Scientific). 90 µg of protein from cell lysates were fractionated by 10% SDS-
PAGE and blotted onto nitrocellulose membranes by the iBlot dry blotting transfer 
system (Invitrogen). Membranes were blocked and incubated with the corresponding 
antibodies as standard procedures. Quantification was done with the Odyssey Infrared 
Imaging System (Li-Cor Biosciences). β-actin was used to normalize gel bands.    
Co-culture of tumour colon cells and CAFs or fibroblasts for migration assays  
Colorectal tumour cell lines were co-cultured with colon primary CAFs or Snail-
modified fibroblast on 8.0 µm-pore Transwells (Corning Incorporated Costar) for 
migration assays. The experiments were performed in Dulbecco’s modified Eagle 
medium (DMEM; Gibco Life Technologies) containing 1% FCS media and 
penicillin/streptomycin antibiotics under standard conditions. Prior to co-culture, 
epithelial cells were labelled with a molecular probe (Cell Tracker Red CMTPX 
C34552, Invitrogen), in line with the manufacturer’s instructions, to distinguish them 
from fibroblasts. Cells were co-cultured with physical separation, in a setting in which 
fibroblasts were seeded in the lower compartment of the transwell and the labelled 
colon cells in the upper one. After 48 h, epithelial cells that had reached the lower 
surface of the filter were recovered by trypsinization and counted by fluorescence with 
the microplate reader (Tecan Infinite 200Pro.) (excitation at 590nm; emission at 635nm) 
through interpolation using a standard curve. 
Conditioned medium harvest and cell cycle analysis by FACs. 
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To obtain conditioned mediums, the standard medium, with 10% FBS, of Mock or 
Snai1 fibroblast cells as well as primary CAFs, was replaced by foetal bovine serum-
free medium and incubated for 24 h. Afterwards, conditioned medium was harvested 
and centrifuged at 1,500 rpm for 6 min to remove cell debris. Mock cells were 
incubated with conditioned medium, diluted 1:4 in standard medium, for 24 h. 
Subsequently, Mock cells were detached from dishes with trypsin, fixed in 70% ethanol 
(-20ºC) for 1 min and treated with 0.2 mg/ml RNase (Qiagen) and propidium iodide 
(Sigma Chemical Co.) at 20 μg/ml in PBS for 15 min at room temperature in darkness. 
Cell DNA content was evaluated in a MACSQuant Analyzer (Miltenyi Biotech). For 
computer analysis, using FACSDiva software (BD Biosciences), only signals from 
single cells were considered (20,000 cells/assay).  
Human protein cytokine array 
1.BR3.G-PCDNA3 and 1.BR3.G-Snail transfected cells (Lipofectamine 2000, 
Invitrogen) were cultured at 37°C in an atmosphere of 5% CO2 for 24 h after 
transfection in DMEM with 10% FBS. Conditioned medium, harvested after 24h 
incubation in DMEM FBS-free medium, was centrifuged at 1,500 g to remove cell 
debris and filtered. Conditioned medium from each transient cell type was prepared and 
incubated with membranes containing an array of 80 human cytokine antibodies 
(RayBio® Human Cytokine Antibody Array 5, RayBiotech Inc.). Procedures carried 
out followed the manufacturer’s instructions. The bound complex was detected with the 
Odyssey Infrared Imaging System (Li-Cor) at 800 nm, using Streptavidin DyLight 800 
Conjugates (Rockland Immunochemicals). The experiment was repeated six times and 
cytokine deregulation was assessed by significant statistical differences. 
Statistical analysis 
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Cell migration and proliferation assays, as well as comparison between mRNA SNAI1 
levels in NFs vs CAFs, were contrasted using the student’s t-test. Correlation of SNAI1 
expression and the induction of colon cell migration or proliferation by primary CAFs 
were analyzed by Pearson’s test. SNAI1, α-SMA and FAP mRNA expression levels were 
analysed as described by Peña et al, 2005 and 2009, and their associations were 
analysed by the Student’s t-test. SNAI1 and cytokine mRNA expression levels in human 
tumour tissues or human primary CAFs were analysed as described by Herrera et al, 
2013, and their associations were analysed by the Pearson correlation test. In 1.BR3G 
and Snail1 KO or wt MEFs, this association was also analysed by the Pearson test. 
In all statistical tests, two-tailed P-values ≤0.05 were considered statistically different. 
All statistical results are derived from 2-4 independent experiments, each performed in 
duplicate.  
Statistical analysis used the SPSS statistical package, version 14.0. 
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Supplementary Figure legends 
Supplementary Figure 1. The absence of epithelial cells in the established primary 
cultures was confirmed by PanCK and Vimentin immunostaining. LIM1215 colon cells 
were used as positive control for PanCK immunostaining (A). Increased expression 
levels of α-SMA, a typical marker of activated fibroblasts, in CAFs versus NFs (B). 
Immunostaining overlapped between SNAI1, a-SMA and FAP in human colon tumour 
samples (C). Correlation between SNAI1 expression levels of CAFs and migration of 
co-cultured LIM1215 or SW480-ADH colon cancer cell migration (D). 
Supplementary Figure 2. The increase in migration and proliferation of colon 
tumours is also observed when Snail1 is expressed by colon cells. Western blot 
analysis of SW480-ADH and 1.BR3G Snail1 transfected cells, as well as Snail1 ko and 
wt MEFs (A). Ectopic expression of Snail1 in fibroblasts enhanced 48h migration of 
LIM1215 colon cancer cells (B). HT29-M6 (C) or LIM1215 (D) migration decreased 
when co-cultured with knock-out MEFs. 48h migration of SW480-ADH-Mock colon 
cancer cells co-cultured with SW480-ADH-Mock and SW480-ADH-Snail1 (E) or with 
HT-29-Mock and HT-29-Snail1 (F).  Proliferation levels at 3 and 6 days of SW480-
ADH-Mock colon cancer cells co-cultured with SW480-ADH-Mock or SW480-ADH-
Snail1 (G). FACS analysis of the cell cycle of colon cancer cells showed an increase in 
S+G2-M phase cells after incubation of cells with conditioned medium from Snail1-
expressing fibroblasts (H). 
Supplementary Figure 3. Snail1-expressing fibroblasts are required for the co-
adjuvant effect of these cells on colon cancer cell invasion in co-xenografted nude 
mice. Lower Snail1 expression is observed in the stromal compartment of tumours 
derived from co-injection of HT29-M6 and Snail1 KO MEFs than of tumours in the 
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control group (A). E-cadherin immunohistochemistry shows protein down-regulation in 
tumours derived from colon cells and Snail KO MEFs. 



